SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001136261-17-000287
Filing Date
2017-11-20
Accepted
2017-11-20 10:51:23
Documents
2
Period of Report
2017-11-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3/A  
1 PRIMARY DOCUMENT primary_doc.xml 3/A 1814
2 POA leonepoa.htm EX-24 3721
  Complete submission text file 0001136261-17-000287.txt   7019
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Issuer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MEADOWLANDS PLAZA EAST RUTHERFORD NJ 07073
Business Address
Leone John R (Reporting) CIK: 0001301047 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-14494 | Film No.: 171212935